Biosimilars in Dermatology – theory becomes reality

Publisher： John Wiley & Sons Inc

E-ISSN： 1610-0387|16|2|150-160

ISSN： 1610-0379

Source： JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, Vol.16, Iss.2, 2018-02, pp. : 150-160

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biosimilars for psoriasis: worldwide overview of regulatory guidelines, uptake and implications for dermatology clinical practice

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 177, Iss. 6, 2017-12 ,pp. : 1495-1502

John Wiley & Sons Inc

Access to resources Recommend Favorite

Biosimilars and haemophilia

By  

HAEMOPHILIA, Vol. 24, Iss. 1, 2018-01 ,pp. : 17-19

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pakistan's CMW program—gap between theory and reality

By  

BJOG : AN INTERNATIONAL JOURNAL OF OBSTETRICS & GYNAECOLOGY, Vol. 122, Iss. 2, 2015-01 ,pp. : 259-259

John Wiley & Sons Inc

Access to resources Recommend Favorite

Biosimilars and Regulatory Authorities

By  

Nephron Clin Pract, Vol. 117, Iss. 1, 2010-08 ,pp. : c1-c7

Karger

Access to resources Recommend Favorite

The State of the Art in the Development of Biosimilars

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 91, Iss. 3, 2012-03 ,pp. : 405-417

John Wiley & Sons Inc

Access to resources Recommend Favorite